X4 Pharmaceuticals, Inc. Share Price
NASDAQ: XFOR | Micro CapX4 Pharmaceuticals, Inc. Stock Performance
X4 Pharmaceuticals, Inc. Share Price Today
As of 29 October 2026, X4 Pharmaceuticals, Inc.'s share price is $3.46. The stock opened at $3.42, compared to its previous close of $3.33. During today's trading session, X4 Pharmaceuticals, Inc.'s share price traded between $3.07 and $3.48, with an average price of $3.27. Over the past 52 weeks, the stock has recorded a high of $4.82 and a low of $2.44. In terms of performance, X4 Pharmaceuticals, Inc.'s share price has declined by 15.20% over the last six months and is down 14.36% on a year-on-year basis.
X4 Pharmaceuticals, Inc. Share Price Chart
X4 Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
X4 Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
X4 Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.87 | $3.46 | +19.10% |
Sep 2026 | $4.04 | $2.90 | -31.24% |
Aug 2026 | $4.00 | $4.22 | +6.42% |
Jul 2026 | $4.63 | $3.97 | -14.90% |
Jun 2026 | $4.20 | $4.67 | +8.36% |
May 2026 | $4.07 | $4.30 | +5.51% |
Apr 2026 | $4.23 | $4.08 | -0.97% |
Mar 2026 | $3.31 | $4.12 | +20.12% |
Feb 2026 | $3.67 | $3.43 | -7.30% |
Jan 2026 | $3.91 | $3.70 | -7.82% |
Dec 2025 | $3.58 | $4.01 | +9.97% |
Nov 2025 | $3.98 | $3.65 | -9.65% |